Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML)

B. Löwenberg, S. Suciu, E. Archimbaud, G. Ossenkoppele, G.E.G. Verhoef, E. Vellenga, P.W. Wijermans, Z. Berneman, A.W. Dekker, P. Stryckmans, H.C. Schouten, U. Jehn, P. Muus, P. Sonneveld, M. Dardenne, R. Zittoun

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2952-2961
Number of pages10
Publication statusPublished - 1997


  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Algemeen onderzoek
  • Immunology

Cite this